news paper icon

Analyzed News

UPDATE 3-Eli Lilly misses sales estimates as top-seller Trulicity disappoints

Eli Lilly and Co's quarterly sales missed Wall Street estimates on Wednesday as the drugmaker offered more discounts or rebates for its top-selling diabetes drug Trulicity, sending shares down 3%. [Source]

Publication Date:

Origin: reuters.com

Category: companyNews

Topics: estimates, trulicity, lilly, misses, co's

Source Link: http://feeds.reuters.com/~r/reuters/companyNews/~3/JfQgzUn7NqE/update-3-eli-lilly-misses-sales-estimates-as-top-seller-trulicity-disappoints-idUSL3N2782KU

Related Articles